Agency news: Roska Healthcare Advertising, Pacific Communications, Havas Worldwide Health Europe

Share this article:
Roska Healthcare Advertising beefed up its staff by 10 – a 20% increase – to accommodate the Astellas business the shop recently won. Astellas named Roska agency of record for consumer on the firm's Vesicare follow-on for overactive bladder, Myrbetriq (mirabegron). The team will be led by SVP Kimberly Clotman. The agency named Dave Zaritsky president back in April, and Jay Bolling continues as CEO.

Pacific Communications was named agency of record for Kimberly-Clark Health Care unit I-Flow Corp.'s On-Q product line of drug delivery, post-surgical pain relief and site care products to US healthcare professionals and potential patients.

Havas Worldwide Health named Ben Davies CEO of its European division. He replaces Ed Stapor in that role and will report into New York-based managing partners and co-CEOs Doug Burcin and Donna Murphy. Davies joins Havas from PAN Advertising, where he was CEO, and previously co-founded and chaired Indigenus, an indie network of healthcare agencies.

Rosetta named Tom Adamski president and Mark Taylor COO. The Publicis shop promoted Adamski from chief consumer technology and entertainment officer and Taylor from chief marketing operations officer. Both report to chairman and CEO Chris Kuenne.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.